Skip to content

Clinical Investigation of Proclear® 1 Day and MyDay® Sphere Contact Lenses

Clinical Investigation of Proclear® 1 Day and MyDay® Sphere Contact Lenses

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07104773
Enrollment
44
Registered
2025-08-05
Start date
2025-07-24
Completion date
2025-08-21
Last updated
2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia, Myopia

Brief summary

The aim of this study is to evaluate and compare the performance of two soft contact lenses.

Detailed description

The aim of this study is to evaluate and compare the performance of a hydrogel lens and a silicone hydrogel lens in existing soft lens wearers.

Interventions

DEVICEControl Lens (omafilcon A)

15 minutes of daily wear

DEVICETest Lens (stenfilcon A)

15 minutes of daily wear

Sponsors

CooperVision International Limited (CVIL)
Lead SponsorINDUSTRY
Centre for Ocular Research & Education, Canada
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Are at least 18 years of age and have capacity to consent; 2. Have understood and signed an information consent form; 3. Are an adapted soft contact lens wearer (worn for at least 3 months); 4. Have a contact lens prescription of -1.00DS to -6.00DS (inclusive) in each eye; 5. Have a refraction with a cylinder component of no more than -0.75DC in each eye; 6. Can achieve a best spectacle-corrected visual acuity in each eye of +0.10 logMAR or better.

Exclusion criteria

1. Participation in a contact lens or contact lens care product clinical trial in the previous 30 days; 2. Have any known active anterior segment disease and/or infection or slit lamp findings that would contraindicate contact lens wear; 3. Have a systemic condition that would contraindicate contact lens wear; 4. Are using any systemic or topical medications that would contraindicate contact lens wear; 5. Have known sensitivity to the diagnostic fluorescein sodium to be used in the study; 6. Are an employee of the study site (Centre for Ocular Research \& Education) and directly involved in the study (ie. on the delegation log).

Design outcomes

Primary

MeasureTime frameDescription
Subjective Comfort RatingAt the end of 15 minutes of daily wearThe primary outcome of this study is lens comfort on a scale of 0-100 (0= worst, 100=best).

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORJill Woods, MSc, MCOptom

Centre of Ocular Research and Education

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026